Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)

SHE:002923 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	308.03	256.17	206.51	213.86	221.03	250.3
Trading Asset Securities	0.03	0.05	0.07	0.05	0.06	0.09
Cash & Short-Term Investments	308.06	256.22	206.58	213.91	221.09	250.39
Cash Growth	52.56%	24.03%	-3.43%	-3.25%	-11.70%	-15.32%
Accounts Receivable	248.73	197.98	213.41	212.11	202.31	160
Other Receivables	3.52	2.61	4.92	3.95	4.03	36.23
Receivables	252.25	200.59	218.34	216.07	206.34	196.23
Inventory	357.37	394.61	442.01	415.45	440.86	335.53
Other Current Assets	5.25	4.83	18.83	21.3	77.95	25.99
Total Current Assets	922.93	856.26	885.75	866.73	946.25	808.14
Property, Plant & Equipment	1,016	1,082	1,209	1,250	1,224	972.57
Long-Term Investments	-	-	-	0.5	0.5	0.5
Other Intangible Assets	62.21	63	64.42	66.05	67.62	69
Long-Term Deferred Tax Assets	12.77	13.9	10.35	10.67	10.8	8.61
Long-Term Deferred Charges	7.32	9.78	13.66	19.93	12.81	13.31
Other Long-Term Assets	3.89	3.42	10.55	14.27	25.23	37.31
Total Assets	2,025	2,029	2,194	2,228	2,287	1,909

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	156.47	143.53	223.36	153.79	213.41	152.5
Accrued Expenses	33.4	115.34	112.39	115.96	178.09	162.56
Short-Term Debt	98.51	132.86	25.04	60.54	62.94	33
Current Portion of Long-Term Debt	-	86.69	106.05	68.82	25.28	-
Current Portion of Leases	-	1.1	2.22	2.11	1.75	2.52
Current Income Taxes Payable	-	-	-	2.26	11.47	0.14
Current Unearned Revenue	9.04	17.92	12.46	10.89	46.68	14.29
Other Current Liabilities	247.4	38.02	42.65	31.93	50.11	57.86
Total Current Liabilities	544.81	535.47	524.16	446.31	589.74	422.87
Long-Term Debt	263.13	309.89	361.67	433.87	377.49	250
Long-Term Leases	1.2	1.77	5.56	7.48	0.98	1.08
Long-Term Unearned Revenue	130.11	136.77	146.52	157.57	120.99	119.74
Long-Term Deferred Tax Liabilities	0.56	0.71	1.73	2.31	0.57	-
Other Long-Term Liabilities	5.94	5.58	1.89	1.07	1.18	3.6
Total Liabilities	945.74	990.19	1,042	1,049	1,091	797.28

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	334.89	334.89	334.89	334.89	239.21	185.71
Additional Paid-In Capital	183.18	183.18	183.18	183.18	278.87	346.23
Retained Earnings	561.08	520.33	634.03	661.08	677.91	594.08
Treasury Stock	-	-	-	-	-	-13.86
Comprehensive Income & Other	-0	-0	0	-0	-	-
Shareholders' Equity	1,079	1,038	1,152	1,179	1,196	1,112
Total Liabilities & Equity	2,025	2,029	2,194	2,228	2,287	1,909

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	362.84	532.32	500.54	572.82	468.43	286.61
Net Cash (Debt)	-54.77	-276.1	-293.96	-358.91	-247.33	-36.22
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.16	-0.83	-0.88	-1.07	-0.73	-0.11
Filing Date Shares Outstanding	367.11	334.89	334.89	334.89	334.89	337.99
Total Common Shares Outstanding	367.11	334.89	334.89	334.89	334.89	337.99
Working Capital	378.12	320.79	361.59	420.42	356.5	385.27
Book Value Per Share	2.94	3.10	3.44	3.52	3.57	3.29
Tangible Book Value	1,017	975.4	1,088	1,113	1,128	1,043
Tangible Book Value Per Share	2.77	2.91	3.25	3.32	3.37	3.09
Buildings	-	540.49	526.75	495.64	399.88	258.75
Machinery	-	1,215	1,173	966.81	848.89	518.23
Construction In Progress	-	19.09	60.3	207.91	295.77	450.37

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error